José Baselga, MD, the chief medical officer of Memorial Sloan Kettering Cancer Center, resigned after it was reported that he failed to disclose any industry ties in 60% of the nearly 180 papers he had published since 2013; an idea to give a push to the president’s plan to disclose drug prices on television was sunk this week by House Republicans; transgender adolescents attempt suicide at a much higher rate than young people whose gender identity matches the sex on their birth certificates.
José Baselga, MD, the chief medical officer of Memorial Sloan Kettering Cancer Center, resigned after ProPublica and The New York Times found that he failed to report any industry ties in 60% of the nearly 180 papers he had published since 2013. That figure increased each year. Last year, he did not disclose any relationships in 87% of the journal articles that he cowrote, according to the report.
An idea to give a push to the president’s plan to disclosed drug prices on television was sunk this week by House Republicans, STAT reported. Senator Dick Durbin, D-Illinois, and Senator Chuck Grassley, R-Iowa, wanted to include an amendment in a major government funding bill that would give the FDA $1 million to kick off advertising idea, which he first floated in May. But the amendment failed to make into a final version being hashed out in a Senate-House reconciliation meeting about the funding bills, aides and Congressman Tom Cole, R-Oklahoma, said.
Transgender adolescents attempt suicide at a much higher rate than young people whose gender identity matches the sex on their birth certificates, according to a new study published this week in Pediatrics. The Washington Post reported on the study, as well as the experience of 1 transgender woman whose experiences led her to create a hotline called Trans Lifeline. The highest rate reported in the study was suffered by transgender male adolescents (51%).
Standard Criteria for Loss of Ambulation Needed in DMD
April 19th 2024A recent study suggests the differences between ambulation definitions for patients with Duchenne muscular dystrophy (DMD) can impact the identification of ambulant vs nonambulant individuals, and standard criteria across settings are needed.
Read More
Overcoming Employment Barriers for Lasting Social Impact: Freedom House 2.0 and Pathways to Work
April 16th 2024To help celebrate and recognize National Minority Health Month, we are bringing you a special month-long podcast series with our Strategic Alliance Partner, UPMC Health Plan. Welcome to our second episode, in which we learn all about Freedom House 2.0 and the Pathways to Work program.
Listen
Early Involvement Critical in Treating Immunotherapy-Induced Overlap Syndrome
April 19th 2024A series of case studies reveals the importance of early diagnosis and involvement of special teams of clinicians when dealing with potential cases of overlap syndrome, which encompasses myocarditis, myasthenia gravis, and immune checkpoint inhibitor–related myositis.
Read More
Making Giant Strides in Maternity Health Through Baby Steps
April 9th 2024To help celebrate and recognize National Minority Health Month, we are kicking off a special month-long podcast series with our strategic alliance partner, UPMC Health Plan. Welcome to our first episode, which is all about the Baby Steps Maternity Program and its mission to support women throughout every step of their pregnancy journey.
Listen